Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007736
Filing Date
2025-05-14
Accepted
2025-05-14 16:05:28
Documents
59
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20250331x10q.htm   iXBRL 10-Q 1366629
2 EX-31.1 tmb-20250331xex31d1.htm EX-31.1 15724
3 EX-32.1 tmb-20250331xex32d1.htm EX-32.1 7014
  Complete submission text file 0001558370-25-007736.txt   4880156

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20250331.xsd EX-101.SCH 41413
5 EX-101.CAL tmb-20250331_cal.xml EX-101.CAL 31288
6 EX-101.DEF tmb-20250331_def.xml EX-101.DEF 173702
7 EX-101.LAB tmb-20250331_lab.xml EX-101.LAB 286312
8 EX-101.PRE tmb-20250331_pre.xml EX-101.PRE 251255
62 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20250331x10q_htm.xml XML 575511
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38191 | Film No.: 25945321
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)